Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The science of PROTACs and MGDs. Traditional drug research has focused on creating inhibitors that occupy the active areas of ...

Inquisite is agentic AI. It doesn't just give you answers, it performs tasks. It can scour research and medical journals faster than a human being, looking for breakthroughs humans can apply.

In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research companies are helping drug developers navigate the current challenging ...

BUFFALO, N.Y. – The Empire Discovery Institute has entered into a collaborative research partnership with the National Multiple Sclerosis Society and its commercial development program Fast Forward, ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and ...

Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...